MetaCap

Jaguar Health Statistics

NASDAQ: JAGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.227-0.10 (-30.58%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Jaguar Health by the numbers

Jaguar Health has a market capitalization of $3.0 million based on 13.35M shares outstanding. With trailing EPS of $-257.15, Jaguar Health is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 93.6% below its 50-day average and 99.7% below its 200-day average.

Average daily trading volume is 2.40M shares, or about $543,902 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

JAGX valuation vs. peer median

JAGX compared with the median of 8 peer companies
MetricJAGXPeer medianDifference
Market cap$3.03M$3.15M-4%
Avg. volume2.40M252.61K+849%

Peer median across 8 companies: SKYE, APUS, GELS, AZTR, MDCX, KPRX, NRSN, APRE.

Valuation

Price / sales (latest FY)
0.26
EPS (TTM)
$-257.15

Price and trading

Previous close
0.327
Open
0.3119
Day range
0.22 – 0.3278
52-week range
0.22 – 981.75
Beta
—
Volume
987.20K

Dividends and events

Annual dividend
None
Next earnings date
Nov 16, 2026

Additional statistics

Market Cap
3.03M
Forward Pe
-0.04
Eps
-257.15
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
981.75
Week52 Low
0.22
Avg Volume
2.40M
Shares Outstanding
13.35M
Ma50
3.52
Ma200
90.58
Earnings Date
Nov 16, 2026
Pct From52w High
-99.98%
Pct From52w Low
3.18%

Related